Online citations, reference lists, and bibliographies.
← Back to Search

Comparative Study On The Cytostatic Effects And The Tissue Distribution Of 5-fluorouracil In A Free Form And Bound To Polybutylcyanoacrylate Nanoparticles In Sarcoma 180-bearing Mice.

J. Kreuter, H. Hartmann
Published 1983 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The binding of 5-fluorouracil to polybutylcyanoacrylate nanoparticles yielded an enhanced efficacy against Crocker sarcoma S 180 and a higher toxicity of the drug measured by induced leukopenia, body weight loss and premature death. The efficacy was further increased by an increase in the polymer-to-drug ratio. The nanoparticles yielded a prolonged persistence of the 5-fluorouracil in all organs examined including the tumor. These particles hold promise as carriers for cytostatics, since their distribution may be favorably altered by coating them with certain proteins or surfactants or by the attachment of monoclonal antibodies.



This paper is referenced by
10.1016/0378-5173(87)90044-5
The effects of polyalkylcyanoacrylate nanoparticles on human normal and malignant mesenchymal cells in vitro
E. Gipps (1987)
10.1016/0168-3659(95)00040-F
Effect of process variables on the in vitro degradation of protein microspheres
G. A. Magee (1995)
10.1016/j.pharmthera.2010.07.007
Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
D. Bharali (2010)
10.1016/0169-409X(90)90017-M
Nanoparticles as microcarriers for anticancer drugs
P. Couvreur (1990)
10.1002/JBM.820241007
In vitro toxicity test of 2-cyanoacrylate polymers by cell culture method.
Y. C. Tseng (1990)
10.1533/9781845698218.66
Nanoparticles – Colloidal Delivery Systems for Drugs and Vaccines
J. Kreuter (2005)
10.1016/S0169-409X(96)00483-8
Nanoparticle drug delivery system for restenosis
V. Labhasetwar (1997)
10.31546/BBAB.1002
Nanoparticles and their Current Potential Use to Detect Monocyte Subsets in Vivo
Mauricio Rojas López (2019)
10.1016/0168-3659(91)90040-K
Nanoparticle-based dmg delivery systems
J. Kreuter (1991)
10.1023/B:BMMD.0000048562.29657.64
Two-Dimensional Chemotherapy Simulations Demonstrate Fundamental Transport and Tumor Response Limitations Involving Nanoparticles
J. Sinek (2004)
10.1016/0378-5173(91)90128-B
Approaches to improve the association of amikacin sulphate to poly(alkylcyanoacrylate) nanoparticles
M. Alonso (1991)
10.1016/S0076-6879(85)12012-4
[10] Poly(alkyl acrylate) nanoparticles
J. Kreuter (1985)
10.1016/0027-5107(92)90085-G
Diminished genotoxicity of mitomycin C and farmorubicin included in polybutylcyanoacrylate nanoparticles.
P. Blagoeva (1992)
10.1007/BF02897200
Tissue distribution of [18F]-5-fluorouracil in mice: effects of route of administration, strain, tumour and dose
G. W. Visser (2008)
10.1016/0378-5173(90)90248-3
Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutylcyanoacrylate nanoparticle preparations
L. Marchal-Heussler (1990)
10.3109/02652049009040471
Separation of drug-loaded nanoparticles from free drug by gel filtration.
P. Beck (1990)
10.1016/0168-3659(91)90058-L
Polyalkylcyanoacrylate nanoparticles as drug carrier: present state and perspectives
P. Couvreur (1991)
Enhancement of Adriamycin Antitumor Activity by Its Binding with an Intracellular Sustained-Release Form, Polymethacrylate Nanospheres, in U-937 Cells1 Alain Astier,2 Bénédicte Doat, Marie-Jeanne Ferrer, Guy Benoit, Jocelyne Fleury, Alain Rolland, and Roger Leverge
Chu H. Mondar (1988)
10.1016/S0928-0987(98)00060-8
In vivo performance of parenteral theophylline-loaded polyisobutylcyanoacrylate nanoparticles in rats.
M. A. Radwan (1999)
10.1016/S0378-5173(96)04842-9
On shelf stability of freeze-dried poly(methylidene malonate 2.1.2) nanoparticles
D. Roy (1997)
10.1016/j.ijpharm.2012.06.022
Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
Cheng Zhang (2012)
10.1016/0378-5173(89)90018-5
Quantitative evaluation of targeted drug delivery systems
Prachi Gupta (1989)
10.1007/s11095-010-0173-z
Nanoparticles: A Promising Modality in the Treatment of Sarcomas
Michiro Susa (2010)
10.1016/j.ijpharm.2010.06.035
Pharmacokinetics of ketorolac loaded to polyethylcyanoacrylate nanoparticles using UPLC MS/MS for its determination in rats.
M. Radwan (2010)
10.1211/0022357001777658
Sustained Release of 5‐Fluorouracil from Polymeric Nanoparticles
P. McCarron (2000)
10.1016/0378-5173(93)90356-K
5 – FLUOROURACIL: VARIOUS KINDS OF LOADED LIPOSOMES ENCAPSULATION EFFICIENCY, STORAGE STABILITY AND FUSOGENIC PROPERTIES
M. Fresta (1993)
10.3109/02652048809056475
Possibilities of using nanoparticles as carriers for drugs and vaccines.
J. Kreuter (1988)
10.1016/0378-5173(86)90021-9
Biodistribution of poly(butyl 2-cyanoacrylate) nanoparticles in rabbits
S. J. Douglas (1986)
10.1201/9781420006636.CH15
Poly(Alkyl Cyanoacrylate) Nanoparticles for Delivery of Anti-Cancer Drugs
R. R. Murthy (2006)
10.3390/molecules13102340
Novel Strategies to Improve the Anticancer Action of 5-Fluorouracil by Using Drug Delivery Systems
José L. Arias (2008)
10.1080/02652040010018146
Preparation and in vivo evaluation of parenteral metoclopramide-loaded poly(alkylcyanoacrylate) nanospheres in rats
M. A. Radwan (2001)
10.1016/j.addr.2011.06.013
Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy.
S. Prakash (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar